Qualified Health launches with $30M and more digital health investment news

Qualified Health, a public benefit corporation that provides the infrastructure for generative AI in healthcare, has launched with $30 million in seed funding.

You are viewing: Qualified Health launches with $30M and more digital health investment news

The funding round was led by SignalFire, Healthier Capital, Town Hall Ventures, and Frist Cressey Ventures, with participation from Intermountain Ventures, Flare Capital Partners, and other companies in the healthcare and technology sectors.

Qualified Health’s technology platform provides healthcare organizations with broad infrastructure to carry out and scale generative AI. 

Key features include enforceable governance, role-based access controls, risk alerts, data privacy protections and safeguards against AI hallucinations.

It also offers healthcare agent creation, which is an infrastructure that enables healthcare teams to rapidly develop and deploy AI agents for workflow automation. 

Post-deployment monitoring provides complete observability of application performance and usage, with human-in-the-loop evaluation and escalation systems. 

See more : Invest in Europe with these attractively priced stocks: Fund manager

The company’s founding team is composed of industry veterans, including Dr. Justin Norden, CEO/cofounder,Shantanu Phatakwala, CCO/cofounder; Beau Norgeot, CAIO/cofounder; Dr. Nirav Shah, cofounder and Dr. Kedar Mate, CMO/cofounder.

“While other industries have seen transformative benefits from generative AI, healthcare adoption has been cautious due to justified concerns about safety and reliability,” Qualified Health board member Sooah Cho from SignalFire, said in a statement. 

“Qualified Health’s infrastructure creates the foundation of trust necessary for healthcare organizations to confidently deploy these powerful tools.”

 VitVio raised $2 million in pre-seed funding led by LDV Capital with participation from Bek Ventures, Tiny Supercomputer Investment Company and angel investors.

The company aims to bring computer vision and AI to surgical theaters to improve operation efficiency, patient outcomes and hospitals’ ROI. The Royal Orthopaedic Hospital NHS Foundation Trust (ROH) began a pilot program with VitVio.

According to the company, by installing cameras and sensors in operating theaters and integrating the hospital’s existing health information systems, VitVio’s AI algorithms operate seamlessly, tracking and analyzing every detail of a surgical procedure, from tool usage and surgical stages to adherence to safety protocols.

See more : Big Lots reaches deal to keep hundreds of stores open – NBC Chicago

“The Royal Orthopaedic Hospital is known as one of the UK’s leading institutions in terms of outcomes and efficiency and, naturally, they have decided to utilize our platform and leverage the cutting-edge AI technology to even further increase the efficiency of surgical procedures,” Thomas Knox, cofounder and CEO at VitVio, said in a statement.

“By autonomously tracking surgical processes and tools, VitVio minimizes the potential for human error and adds no extra steps to the surgical process, aligning with industry experts’ consensus on the importance of non-intrusive technology.”

Healthcare venture capital firm Allumia Ventures, previously Providence Ventures, announced it spun off from Providence to become an independent venture capital firm following a first close of its third fund. The company seeks to bring on additional investors.

In a statement, Allumia said it will continue to work with Providence in its capacity as an Anchor Limited Partner. Providence pledged $150 million toward Allumia’s third fund over its life of ten years. 

Allumia Ventures appeared in 2015 as a bridge between best-in-class health care solutions and the complex health care ecosystem. 

Initially managing funds exclusively for Providence, Allumia has since extended its scope to include partnerships with mission-driven health care organizations.

“Providence’s investments have been and will continue to be focused on fostering innovation, enhancing health care access and addressing critical issues facing the health sector,” Greg Hoffman, Providence’s CFO, said in a statement.

“Allumia branching out will allow the fund to extend its reach, drive impactful investments that align with our Mission and support leading-edge health solutions.”